Advertisement
U.S. Markets open in 3 hrs 43 mins

ME Therapeutics Holdings Inc. (Q9T.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
3.3400+0.3200 (+10.60%)
As of 09:59AM CEST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
8/31/2023
9/30/2022
8/31/2022
Total Revenue
0
0
0
0
Operating Expense
1,391
977.371
295.267
134.984
Operating Income
-1,391
-977.371
-295.267
-134.984
Net Non Operating Interest Income Expense
24.424
3.949
-7.976
-10.8
Other Income Expense
-
-5,547
-3,002
-
Pretax Income
-3,930
-6,520
-3,305
-145.784
Net Income Common Stockholders
-3,930
-6,520
-3,305
-145.784
Diluted NI Available to Com Stockholders
-3,930
-6,520
-3,305
-145.784
Basic EPS
-0.28
-0.28
-
-0.01
Diluted EPS
-0.28
-0.28
-
-0.01
Basic Average Shares
23,561
23,561
-
23,176
Diluted Average Shares
23,561
23,561
-
23,176
Total Operating Income as Reported
-1,438
-984.833
-323.067
-162.784
Total Expenses
1,391
977.371
295.267
134.984
Net Income from Continuing & Discontinued Operation
-3,930
-6,520
-3,305
-145.784
Normalized Income
1,637
-953.422
-3,305
-145.784
Interest Income
24.424
11.411
2.824
0
Interest Expense
0
7.462
10.8
10.8
Net Interest Income
24.424
3.949
-7.976
-10.8
EBIT
-3,930
-6,513
-3,294
-134.984
EBITDA
-3,929
-6,513
-3,294
-134.923
Reconciled Depreciation
0.042
0.049
0.061
0.061
Net Income from Continuing Operation Net Minority Interest
-3,930
-6,520
-3,305
-145.784
Total Unusual Items Excluding Goodwill
-5,567
-5,567
-
0
Total Unusual Items
-5,567
-5,567
-
0
Normalized EBITDA
1,637
-945.911
-3,294
-134.923
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0